Acorda Therapeutics (ACOR)
NASDAQ:ACOR

Acorda Therapeutics (ACOR) Stock Investors

586 Followers
Based on 646,998 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold ACOR
On average, investors allocate 3.01% of their portfolios to ACOR
The average holding size of this company in investors' portfolios.

Investor Sentiment

Neutral
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 646,998 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding ACOR

0.8%
Last 7
Days
1.1%
Last 30
Days
Percentages indicate the change in the number of portfolios holding ACOR, out of 646,998 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

ACOR Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
0.36%
$1.00
Based on the activity of 12,132 investors who made their portfolios public
The table shows changes in ACOR in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

ACOR Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Moderna
5.63%
-0.03%
+0.11%
$48.12B
Healthcare
General Electric
5.83%
-0.34%
+2.21%
$111.88B
Industrials
Syros Pharmaceuticals
3.88%
-0.85%
-4.84%
$76.20M
Healthcare
Nikola
5.38%
-0.65%
-2.42%
$409.24M
Energy
Applied Materials
4.77%
+0.72%
+1.61%
$114.99B
Technology
DraftKings
6.02%
-0.36%
+0.51%
$19.99B
Technology
AMC Entertainment
6.50%
-0.38%
-2.23%
$7.03B
Consumer Cyclical
Twilio
3.10%
-0.43%
-0.56%
$11.05B
Technology
Cloudflare
4.02%
-0.45%
+0.76%
$20.29B
Technology
CVS Health
4.04%
+0.18%
+4.86%
$86.72B
Healthcare
Based on the activity of 646,998 active portfolios
Open your Smart Portfolio

ACOR Investor Analysis

ACOR investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
25.5%
of ACOR holders
are under 35
Average Segment Performance
Average P/E Ratio37.63
Beta4.97
Dividend Yield5.14%
ACOR investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
54.5%
of ACOR holders
are between 35–55
Average Segment Performance
Average P/E Ratio40.55
Beta4.92
Dividend Yield6.17%
ACOR investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
20.0%
of ACOR holders
are over 55
Average Segment Performance
Average P/E Ratio40.40
Beta0.42
Dividend Yield5.67%
Overview of age group and performance of ACOR stock investors
See who invests in ACOR according to age group and performance.

FAQ

How many retail Investors hold ACOR?
<0.1% of TipRank’s retail investors hold ACOR in their portfolios.
    What is ACOR Investor Sentiment?
    ACOR’s Investor Sentiment is Neutral.
      What percentage of retail investors changed their holding of ACOR in the last 7 days?
      ▼ 0.8% of TipRank’s retail investors changed their holding of ACOR in the last 7 days.
        What percentage of retail investors changed their holding of ACOR in the last 30 days?
        ▲ 1.1% of TipRank’s retail investors changed their holding of ACOR in the last 30 days.
          What is the average age of retail investors who hold ACOR?
          The average age of ACOR Holders is between 35–55.
            What other stocks have ACOR investors also bought?
            ACOR Investors also bought MRNA, GE, SYRS, NKLA, AMAT, DKNG, AMC, TWLO, NET, CVS.

              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              ABCAmerisourceBergen
              BCRXBioCryst
              BLRXBioline RX Ltd Sponsored ADR
              BIOBio-Rad Laboratories

              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis